S&P 500   4,352.63 (-2.04%)
DOW   34,299.99 (-1.63%)
QQQ   360.13 (-2.76%)
AAPL   141.98 (-2.33%)
MSFT   283.57 (-3.60%)
FB   340.82 (-3.61%)
GOOGL   2,717.23 (-3.69%)
TSLA   777.67 (-1.73%)
AMZN   3,319.98 (-2.52%)
NVDA   207.08 (-4.40%)
BABA   152.06 (+1.25%)
NIO   35.22 (-4.22%)
CGC   14.20 (-3.47%)
GE   105.85 (+0.47%)
MU   73.24 (-2.58%)
AMD   101.50 (-6.16%)
T   27.28 (-0.44%)
F   14.32 (+1.13%)
ACB   6.84 (+7.04%)
DIS   174.41 (-2.16%)
PFE   43.08 (-1.12%)
BA   218.75 (-2.41%)
AMC   37.19 (-5.37%)
S&P 500   4,352.63 (-2.04%)
DOW   34,299.99 (-1.63%)
QQQ   360.13 (-2.76%)
AAPL   141.98 (-2.33%)
MSFT   283.57 (-3.60%)
FB   340.82 (-3.61%)
GOOGL   2,717.23 (-3.69%)
TSLA   777.67 (-1.73%)
AMZN   3,319.98 (-2.52%)
NVDA   207.08 (-4.40%)
BABA   152.06 (+1.25%)
NIO   35.22 (-4.22%)
CGC   14.20 (-3.47%)
GE   105.85 (+0.47%)
MU   73.24 (-2.58%)
AMD   101.50 (-6.16%)
T   27.28 (-0.44%)
F   14.32 (+1.13%)
ACB   6.84 (+7.04%)
DIS   174.41 (-2.16%)
PFE   43.08 (-1.12%)
BA   218.75 (-2.41%)
AMC   37.19 (-5.37%)
S&P 500   4,352.63 (-2.04%)
DOW   34,299.99 (-1.63%)
QQQ   360.13 (-2.76%)
AAPL   141.98 (-2.33%)
MSFT   283.57 (-3.60%)
FB   340.82 (-3.61%)
GOOGL   2,717.23 (-3.69%)
TSLA   777.67 (-1.73%)
AMZN   3,319.98 (-2.52%)
NVDA   207.08 (-4.40%)
BABA   152.06 (+1.25%)
NIO   35.22 (-4.22%)
CGC   14.20 (-3.47%)
GE   105.85 (+0.47%)
MU   73.24 (-2.58%)
AMD   101.50 (-6.16%)
T   27.28 (-0.44%)
F   14.32 (+1.13%)
ACB   6.84 (+7.04%)
DIS   174.41 (-2.16%)
PFE   43.08 (-1.12%)
BA   218.75 (-2.41%)
AMC   37.19 (-5.37%)
S&P 500   4,352.63 (-2.04%)
DOW   34,299.99 (-1.63%)
QQQ   360.13 (-2.76%)
AAPL   141.98 (-2.33%)
MSFT   283.57 (-3.60%)
FB   340.82 (-3.61%)
GOOGL   2,717.23 (-3.69%)
TSLA   777.67 (-1.73%)
AMZN   3,319.98 (-2.52%)
NVDA   207.08 (-4.40%)
BABA   152.06 (+1.25%)
NIO   35.22 (-4.22%)
CGC   14.20 (-3.47%)
GE   105.85 (+0.47%)
MU   73.24 (-2.58%)
AMD   101.50 (-6.16%)
T   27.28 (-0.44%)
F   14.32 (+1.13%)
ACB   6.84 (+7.04%)
DIS   174.41 (-2.16%)
PFE   43.08 (-1.12%)
BA   218.75 (-2.41%)
AMC   37.19 (-5.37%)
NYSE:TFX

Teleflex Stock Forecast, Price & News

$387.84
+0.62 (+0.16 %)
(As of 09/28/2021 03:57 PM ET)
Add
Compare
Today's Range
$380.98
$389.67
50-Day Range
$360.30
$404.61
52-Week Range
$312.33
$449.38
Volume16,695 shs
Average Volume248,374 shs
Market Capitalization$18.15 billion
P/E Ratio52.34
Dividend Yield0.35%
Beta1.19
30 days | 90 days | 365 days | Advanced Chart
Receive TFX News and Ratings via Email

Sign-up to receive the latest news and ratings for Teleflex and its competitors with MarketBeat's FREE daily newsletter.


Teleflex logo

About Teleflex

Teleflex, Inc. provides medical technology products which enables healthcare providers to improve patient outcomes and enhance patient and provider safety. The firm designs, develops, manufactures and supplies single-use medical devices used by hospitals and healthcare providers for common diagnostic and therapeutic procedures in critical care and surgical applications. It operates through the following business segments: Americas, EMEA (Europe, the Middle East and Africa), Asia (Asia Pacific) and OEM. The Americas segment engages in the sales of interventional urology products. The EMEA engages in the sales of urology products. The Asia segment designs, manufactures and distributes medical devices primarily used in critical care, surgical applications and cardiac care and generally serves hospitals and healthcare providers. The OEM segment designs, manufactures and supplies devices and instruments for other medical device manufacturers. The company was founded in 1943 and is headquartered in Wayne, PA.

Headlines

See More Headlines

Industry, Sector and Symbol

Industry
Surgical & medical instruments
Sub-Industry
Health Care Equipment
Sector
Medical
CUSIP
87936910
Employees
14,000
Year Founded
1943

Sales & Book Value

Annual Sales
$2.54 billion
Cash Flow
$16.46 per share
Book Value
$71.65 per share

Profitability

Net Income
$335.32 million

Debt

Price-To-Earnings

Miscellaneous

Market Cap
$18.15 billion
Next Earnings Date
11/4/2021 (Estimated)
Optionable
Optionable

Social Links


MarketRank

Overall MarketRank

2.60 out of 5 stars

Medical Sector

68th out of 1,353 stocks

Surgical & Medical Instruments Industry

7th out of 123 stocks

Analyst Opinion: 3.5Community Rank: 4.1Dividend Strength: 1.7Insider Behavior: 2.5Valuation: 1.3 5 -4 -3 -2 -1 -












Teleflex (NYSE:TFX) Frequently Asked Questions

Is Teleflex a buy right now?

10 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Teleflex in the last twelve months. There are currently 1 hold rating and 9 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "buy" Teleflex stock.
View analyst ratings for Teleflex
or view top-rated stocks.

What stocks does MarketBeat like better than Teleflex?

Wall Street analysts have given Teleflex a "Buy" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but Teleflex wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

Are investors shorting Teleflex?

Teleflex saw a decrease in short interest in the month of August. As of August 31st, there was short interest totaling 520,900 shares, a decrease of 38.7% from the August 15th total of 849,200 shares. Based on an average trading volume of 335,800 shares, the short-interest ratio is currently 1.6 days. Currently, 1.1% of the shares of the stock are short sold.
View Teleflex's Short Interest
.

When is Teleflex's next earnings date?

Teleflex is scheduled to release its next quarterly earnings announcement on Thursday, November 4th 2021.
View our earnings forecast for Teleflex
.

How were Teleflex's earnings last quarter?

Teleflex Incorporated (NYSE:TFX) announced its quarterly earnings results on Thursday, July, 29th. The medical technology company reported $3.35 EPS for the quarter, beating the Thomson Reuters' consensus estimate of $2.87 by $0.48. The medical technology company earned $713.47 million during the quarter, compared to analysts' expectations of $680.85 million. Teleflex had a net margin of 13.06% and a trailing twelve-month return on equity of 17.29%. During the same period last year, the business earned $1.93 EPS.
View Teleflex's earnings history
.

How has Teleflex's stock been impacted by Coronavirus (COVID-19)?

Teleflex's stock was trading at $342.08 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization. Since then, TFX stock has increased by 13.4% and is now trading at $387.95.
View which stocks have been most impacted by COVID-19
.

How often does Teleflex pay dividends? What is the dividend yield for Teleflex?

Teleflex declared a quarterly dividend on Thursday, July 29th. Investors of record on Monday, August 16th will be given a dividend of $0.34 per share on Wednesday, September 15th. This represents a $1.36 annualized dividend and a dividend yield of 0.35%. The ex-dividend date of this dividend is Friday, August 13th.
View Teleflex's dividend history
.

Is Teleflex a good dividend stock?

Teleflex pays an annual dividend of $1.36 per share and currently has a dividend yield of 0.35%. Teleflex does not yet have a strong track record of dividend growth. The dividend payout ratio of Teleflex is 12.75%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, Teleflex will have a dividend payout ratio of 9.32% next year. This indicates that Teleflex will be able to sustain or increase its dividend.
View Teleflex's dividend history.

What guidance has Teleflex issued on next quarter's earnings?

Teleflex updated its FY 2021 earnings guidance on Thursday, August, 5th. The company provided earnings per share (EPS) guidance of $12.900-$13.100 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $12.750. The company issued revenue guidance of $2.80 billion-$2.84 billion, compared to the consensus revenue estimate of $2.82 billion.

What price target have analysts set for TFX?

10 Wall Street analysts have issued twelve-month price objectives for Teleflex's stock. Their forecasts range from $415.00 to $486.00. On average, they anticipate Teleflex's share price to reach $455.80 in the next twelve months. This suggests a possible upside of 17.5% from the stock's current price.
View analysts' price targets for Teleflex
or view top-rated stocks among Wall Street analysts.

Who are Teleflex's key executives?

Teleflex's management team includes the following people:
  • Liam J. Kelly, Chairman, President & Chief Executive Officer
  • Thomas E. Powell, Chief Financial Officer & Executive Vice President
  • Timothy F. Duffy, Chief Information Officer & Vice President
  • Michelle Fox, Chief Medical Officer & Vice President
  • Gwen Chapman, Chief Compliance Officer & Vice President

What is Liam Kelly's approval rating as Teleflex's CEO?

73 employees have rated Teleflex CEO Liam Kelly on Glassdoor.com. Liam Kelly has an approval rating of 86% among Teleflex's employees.

What other stocks do shareholders of Teleflex own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Teleflex investors own include NVIDIA (NVDA), AbbVie (ABBV), Johnson & Johnson (JNJ), Alibaba Group (BABA), Lam Research (LRCX), ServiceNow (NOW), QUALCOMM (QCOM), Advanced Micro Devices (AMD), salesforce.com (CRM) and Cisco Systems (CSCO).

What is Teleflex's stock symbol?

Teleflex trades on the New York Stock Exchange (NYSE) under the ticker symbol "TFX."

Who are Teleflex's major shareholders?

Teleflex's stock is owned by a variety of retail and institutional investors. Top institutional investors include Price T Rowe Associates Inc. MD (12.12%), Vanguard Group Inc. (10.62%), BlackRock Inc. (10.54%), State Street Corp (3.99%), American Century Companies Inc. (2.81%) and Marshall Wace LLP (1.96%). Company insiders that own Teleflex stock include Benson Smith, Cameron P Hicks, James J Leyden, John Deren, Liam Kelly, Stephen K MD Klasko, Stuart A Randle and Thomas E Powell.
View institutional ownership trends for Teleflex
.

Which major investors are selling Teleflex stock?

TFX stock was sold by a variety of institutional investors in the last quarter, including American Century Companies Inc., Mar Vista Investment Partners LLC, BlackRock Inc., APG Asset Management N.V., Atlanta Capital Management Co. L L C, Nuveen Asset Management LLC, William Blair Investment Management LLC, and Invesco Ltd.. Company insiders that have sold Teleflex company stock in the last year include Cameron P Hicks, Liam Kelly, Stephen K MD Klasko, and Stuart A Randle.
View insider buying and selling activity for Teleflex
or view top insider-selling stocks.

Which major investors are buying Teleflex stock?

TFX stock was purchased by a variety of institutional investors in the last quarter, including Price T Rowe Associates Inc. MD, FMR LLC, JPMorgan Chase & Co., Amundi, Marshall Wace LLP, Citadel Advisors LLC, Kimelman & Baird LLC, and Woodline Partners LP.
View insider buying and selling activity for Teleflex
or or view top insider-buying stocks.

How do I buy shares of Teleflex?

Shares of TFX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Teleflex's stock price today?

One share of TFX stock can currently be purchased for approximately $387.95.

How much money does Teleflex make?

Teleflex has a market capitalization of $18.16 billion and generates $2.54 billion in revenue each year. The medical technology company earns $335.32 million in net income (profit) each year or $10.67 on an earnings per share basis.

How many employees does Teleflex have?

Teleflex employs 14,000 workers across the globe.

When was Teleflex founded?

Teleflex was founded in 1943.

What is Teleflex's official website?

The official website for Teleflex is www.teleflex.com.

Where are Teleflex's headquarters?

Teleflex is headquartered at 550 E SWEDESFORD RD, WAYNE PA, 19087.

How can I contact Teleflex?

Teleflex's mailing address is 550 E SWEDESFORD RD, WAYNE PA, 19087. The medical technology company can be reached via phone at (610) 225-6800 or via email at [email protected].


This page was last updated on 9/28/2021 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.